A387V (p.Ala387Val) variant of GCK (Hexokinase-4)

A387V (p.Ala387Val) in GCK (Hexokinase-4) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as pathogenic in the context of Monogenic diabetes. The available variant effect predictions contribute to a CATVariant prioritization score of 0.85 / 1. The record also includes population frequency data, published literature, and structural context.

A387V (p.Ala387Val) variant details